Evidence map›Paper›PMID 36159433›Full record

ArticleWorld journal of clinical cases2022

Supratentorial hemangioblastoma at the anterior skull base: A case report.

Si-Ting Xu, Xin Cao, Xu-Yang Yin, Jing-Yi Zhang, Jin Nan, Jun Zhang

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Si-Ting XuDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xin CaoDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xu-Yang YinDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Jing-Yi ZhangDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Jin NanDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Jun ZhangDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China. m18764209657@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemangioblastoma (HB) is a rare tumor, comprising about 2% of all intracranial tumors. Although it is a benign tumor, due to the abundant blood supply and its close relationship with adjacent cerebral blood vessels, surgical resection is difficult and may cause complications such as bleeding. If HB can be correctly diagnosed before surgery, complications can be avoided by methods such as vascular embolism before surgery. CASE SUMMARY: A 51-year-old male patient was admitted to our hospital because of blurred vision in his left eye for 2 years. Ophthalmological examination revealed oculus dexter vision acuity of 1.0 and oculus sinister vision acuity of 0.6. His left vision had tubular visual field, while his right vision had a partial defect. Computed tomography and magnetic resonance imaging showed a mass lesion at the left anterior base of the skull, which could have been a meningioma. During the operation, the tumor was found to be located at the entrance of the left optic nerve tube, closely adhering to the left optic nerve and the blood supply was extremely abundant. The tumor was carefully separated and diagnosed as HB postoperatively after pathological examination.

conclusionA rare HB at the anterior skull base could be distinguished by its imaging features, which is essential to the surgical procedures.

Indexed as

Anterior skull baseCase reportDiagnosisHemangioblastomaMagnetic resonance imagingSupratentorial

Identifiers

PMID36159433
PMCPMC9477685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.